Edgewise Therapeutics, Inc. Public Float
Edgewise Therapeutics, Inc. (EWTX) had Public Float of $1.20 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $1.20B.
- 2024-06-30: Entity Public Float $1.40B.
- 2023-06-30: Entity Public Float $386.00M.
- 2022-06-30: Entity Public Float $247.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.20B 10-K · filed 2026-02-26 |
| 2024-06-30 | $1.40B 10-K · filed 2025-03-03 |
| 2023-06-30 | $386.00M 10-K · filed 2024-02-22 |
| 2022-06-30 | $247.90M 10-K · filed 2023-02-23 |
| 2021-06-30 | $653.40M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |